TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 DKK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover |
436
|
775
|
791 |
Financial expenses |
30
|
0
|
1 |
Earnings before taxes |
39
|
279
|
465 |
EBITDA |
68
|
73
|
75 |
Total assets |
2,045
|
2,553
|
2,684 |
Current assets |
185
|
239
|
242 |
Current liabilities |
111
|
217
|
245 |
Equity capital |
1,829
|
2,176
|
2,255 |
- share capital |
63
|
70
|
73 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency |
89.4%
|
85.2%
|
84.0% |
Turnover per employee |
436
|
775
|
791 |
Profit as a percentage of turnover |
8.9%
|
36.0%
|
58.8% |
Return on assets (ROA) |
3.4%
|
10.9%
|
17.4% |
Current ratio |
166.7%
|
110.1%
|
98.8% |
Return on equity (ROE) |
2.1%
|
12.8%
|
20.6% |
Change turnover |
-266
|
24
|
-239 |
Change turnover % |
-38%
|
3%
|
-23% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.